Latest Crealta Pharmaceuticals LLC Stories
Acquisition is highlighted by KRYSTEXXA® (pegloticase), the only product approved for the treatment of refractory chronic gout GLENDALE, Wis., Jan. 10, 2014 /PRNewswire/ -- Crealta Pharmaceuticals LLC ("Crealta"), a new specialty pharmaceutical company, announced today the completion of the acquisition of substantially all of the assets of Savient Pharmaceuticals, Inc. ("Savient"). Crealta previously announced the winning of an auction for these assets, the signing of a definitive...
- A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
- A ghost, wraith, hobgoblin, elf, or spirit.